GCLabs

Search for Test Items

Plasminogen activator inhibitor-1 (PAI-1)

GC Labs code	S810	Test Field	Hematology
Compulsory forms

GC Labs code

S810

Test Field

Hematology

Compulsory forms

Information

Test method	ELISA (Enzyme linked immunosorbent assay)
Specimen (mL)	Sod. citrate P 0.5
Specimen storage	Frozen
Specimen stability	Ambient (4 hours), Frozen (1 month)
Test schedule	Wed
Analytical time (day)	1

Test method

ELISA (Enzyme linked immunosorbent assay)

Specimen (mL)

Sod. citrate P 0.5

Specimen storage

Frozen

Specimen stability

Ambient (4 hours), Frozen (1 month)

Test schedule

Wed

Analytical time (day)

Reference range/Unit	[Plasma] 4.0 ~ 43.0 (ng/mL)
Clinical Significance	Plasma plasminogen activator inhibitor, PAI-1 is a major inhibitor of fibrinolysis. The 4G variant (AF386492.2:g.837del) in the PAI-1 (Serpine 1) gene promoter region is associated with an increase in the level of PAI-1 in plasma. Increased levels of PAI-1 in plasma may increase the risk for arterial and venous thrombosis, myocardial infarction, and progression of atherosclerosis and also recurrent spontaneous abortion.
Remark	After collection, centrifuge immediately and store frozen

Reference range/Unit

 [Plasma]
4.0 ~ 43.0 (ng/mL)

Clinical Significance

Plasma plasminogen activator inhibitor, PAI-1 is a major inhibitor of fibrinolysis. The 4G variant (AF386492.2:g.837del) in the PAI-1 (Serpine 1) gene promoter region is associated with an increase in the level of PAI-1 in plasma. Increased levels of PAI-1 in plasma may increase the risk for arterial and venous thrombosis, myocardial infarction, and progression of atherosclerosis and also recurrent spontaneous abortion.

Remark

After collection, centrifuge immediately and store frozen